Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight‐Patient Case Series in the Pre‐ siRNA Era
Pediatric Transplantation · 2025
DOI: 10.1111/petr.70225 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Transplantation, 2025. Verfasst von Gal Finer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Nephrology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Hyperoxaluria, Primary, Liver Transplantation, Kidney Transplantation. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disorder that leads to systemic oxalosis and end‐stage renal disease (ESRD). Before the advent of siRNA therapy, liver transplantation, often combined with kidney transplantation, was the only definitive treatment.
Methods
We conducted a retrospective review of eight pediatric patients with PH1 who underwent liver transplantation at a single tertiary care institution between 1998 and 2018. Clinical records were reviewed to extract data on transplant strategy, timing and modality of dialysis, surgical technique, and long‐term outcomes. Histopathological and imaging data were used to assess systemic oxalate deposition.
Results
Five patients underwent sequential liver‐kidney transplantation (seqLKT), one received preemptive liver transplantation, and two received kidney transplantation prior to PH1 diagnosis. To reduce systemic oxalate burden, seqLKT patients received intensive dialysis bridging. Following an early case of hepatic artery thrombosis, arterial conduit reconstruction to the aorta was employed in subsequent cases to optimize hepatic inflow. Oxalate deposition in arterial walls, retina, or bone was documented in three patients. At a median follow‐up of 7.5 years, seven of eight patients were alive with stable hepatic and renal graft function.
Conclusions
This case series illustrates the surgical complexity and multidisciplinary coordination required in pediatric PH1 management and supports the role of seqLKT with conduit‐based hepatic artery reconstruction and intensive dialysis bridging as effective approaches in selected patients, particularly in settings without access to gene‐targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Nephrology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Feinberg School of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Division of Pediatric Surgery, Children's Hospital at Montefiore, Albert Einstein College of Medicine, New York, New York, USA.
- Division of Transplant Surgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Division of Pathology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
ORCID-Profile: Riccardo Superina
Zitieren
APA
Finer, G., Darani, A. N., Switalski, M. G., Ward, S. E., Melin-Aldana, H., & Superina, R. (2025). Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight‐Patient Case Series in the Pre‐ siRNA Era. Pediatric Transplantation. https://doi.org/10.1111/petr.70225
Vancouver
Finer G, Darani AN, Switalski MG, Ward SE, Melin-Aldana H, Superina R. Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight‐Patient Case Series in the Pre‐ siRNA Era. Pediatric Transplantation. 2025. doi:10.1111/petr.70225
BibTeX
@article{Finer2025,
author = {Finer, Gal and Darani, Alexandre N and Switalski, Matthew G and Ward, Sarah E and Melin-Aldana, Hector and Superina, Riccardo},
title = {Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight‐Patient Case Series in the Pre‐ siRNA Era},
journal = {Pediatric Transplantation},
year = {2025},
doi = {10.1111/petr.70225}
}
EUVIMED